Spark Investment Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Spark Investment Management’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,475	Closed	-$208K	–	737
2019 Q1	$208K	Sell	12,475 -23,900	-66%	-$344K	0.01%	497
2018 Q4	$417K	Buy	+36,375	New	+$736K	0.03%	418
2015 Q2	–	Sell	-4,175	Closed	-$148K	–	748
2015 Q1	$148K	Buy	+4,175	New	+$183K	0.02%	587
2014 Q4	–	Sell	-3,015	Closed	-$77K	–	823
2014 Q3	$77K	Buy	+3,015	New	+$93.1K	0.01%	614

Other funds holding MRNS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Spark Investment Management's MRNS Position: Q2 2019 in Review

Spark Investment Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2019, closing a stake of 12,475 shares — an estimated $208K sold.

Spark Investment Management first reported a position in MRNS in Q3 2014 and held it in 4 quarters. The position peaked at $417K in Q4 2018. 77 funds tracked by Wall St. Rank hold MRNS as of Q2 2019.

Spark Investment Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2019 after selling out during the quarter.
Spark Investment Management sold 12,475 Marinus Pharmaceuticals, Inc shares in Q2 2019, an estimated $208K.
Spark Investment Management first reported a position in Marinus Pharmaceuticals, Inc in Q3 2014 and held it in 4 quarters.
Spark Investment Management's Marinus Pharmaceuticals, Inc position peaked at $417K in Q4 2018.
77 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.